JOHNSON & JOHNSON INTERNATIONAL

Johnson & Johnson International, operating under NAICS 339113 for medical device manufacturing, specializes in the design, production, and quality assurance of regulated medical devices and diagnostics. The company’s core capabilities center on precision manufacturing processes compliant with FDA 21 CFR Part 820, ISO 13485 quality management systems, and sterile packaging protocols. Technical expertise includes cleanroom operations, biocompatibility testing, regulatory documentation submission, and supply chain traceability for Class II and III medical devices. Specializations in automated assembly, materials science for implantables, and sterilization validation distinguish their production environment, ensuring consistent compliance with global regulatory standards. No award history is available to infer specific agency relationships or project types, so no agency experience can be confirmed. The primary NAICS classification indicates a focus on surgical and medical instrument manufacturing, translating to high-precision, low-volume production of specialized devices used in clinical and hospital settings. This positions the company within the regulated medical technology vertical, serving markets requiring stringent documentation, risk management, and post-market surveillance systems. The entity is structured as a 2L-level business with a physical presence in Guaynabo, Puerto Rico, indicating a localized manufacturing footprint. No government certifications such as 8(a), HUBZone, or SDVOSB are listed, and there is no indication of federal procurement certifications. The company’s market positioning is rooted in industrial manufacturing capacity rather than federal contracting, suggesting a primary orientation toward commercial healthcare supply chains rather than direct government procurement channels.